Electromed, Inc.
Business
Electromed, Inc. develops, manufactures, markets and sells the SmartVest Airway Clearance System, a high-frequency chest wall oscillation (HFCWO) device for patients with compromised pulmonary function including bronchiectasis, cystic fibrosis, and neuromuscular conditions. The company operates a direct-to-patient and provider model, managing insurance claims and delivering systems to patients in homecare and acute-care settings, thereby capturing manufacturer and distributor margins. The SmartVest System is sold primarily to domestic homecare markets through a physician referral model and to hospitals; international sales occur through independent distributors in select territories.
Summary from 10-K filed 2025-08-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net revenues | 64 | 55 | — | — | — | |
| Cost of revenues | 14 | 13 | 12 | 10 | 8 | |
| Gross profit | 50 | 42 | 37 | 31 | 27 | |
| Selling, general and administrative | 39 | 34 | 32 | 27 | 22 | |
| Research and development | 996,000 | 656,000 | 916,000 | 1 | 2 | |
| Total operating expenses | 40 | 35 | 33 | 28 | 24 | |
| Operating income | 10 | 7 | 4 | 3 | 3 | |
| Interest income, net | 624,000 | 455,000 | — | — | — | |
| Net income before income taxes | 10 | 7 | 4 | 3 | 3 | |
| Income tax expense | 3 | 2 | 920,000 | 692,000 | 805,000 | |
| Net income | 8 | 5 | 3 | 2 | 2 | |
| Basic (in dollars per share) | 0.89 | 0.6 | 0.37 | 0.27 | 0.28 | |
| Diluted (in dollars per share) | 0.85 | 0.58 | 0.36 | 0.26 | 0.27 | |
| Basic (in shares) | 8 | 9 | 8 | 8 | 9 | |
| Diluted (in shares) | 9 | 9 | 9 | 9 | 9 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 15 | 16 | 7 | 8 | 12 | |
| Accounts receivable (net of allowances for credit losses of $45,000) | 25 | 23 | 24 | 21 | 17 | |
| Contract assets | 1 | 719,000 | 487,000 | 286,000 | 393,000 | |
| Inventories | 3 | 4 | 4 | 3 | 2 | |
| Prepaid expenses and other current assets | 392,000 | 329,000 | 2 | 2 | 276,000 | |
| Income tax receivable | 408,000 | 0 | — | — | — | |
| Total current assets | 45 | 44 | 38 | 35 | 32 | |
| Net property and equipment | 5 | 5 | 6 | 5 | 4 | |
| Finite-life intangible assets, net | 371,000 | 657,000 | 605,000 | 599,000 | 663,000 | |
| Other Assets, Noncurrent | 1 | 87,000 | 161,000 | 120,000 | 88,000 | |
| Deferred income taxes | 2 | 2 | 2 | 2 | 1 | |
| Total assets | 54 | 52 | 46 | 41 | 37 | |
| Accounts payable | 3 | 1 | 1 | 1 | 685,000 | |
| Accrued compensation | 5 | 4 | 3 | 3 | 2 | |
| Income tax payable | 0 | 277,000 | 336,000 | 51,000 | 288,000 | |
| Warranty reserve | 2 | 2 | — | — | — | |
| Other Accrued Liabilities, Current | 1 | 930,000 | — | — | — | |
| Total current liabilities | 10 | 8 | 8 | 7 | 5 | |
| Other long-term liabilities | 125,000 | 12,000 | — | — | — | |
| Total liabilities | 11 | 8 | 8 | 7 | 5 | |
| Common stock, $0.01 par value per share, 13,000,000 shares authorized; 8,349,176 and 8,637,883 shares issued and outstanding, as of June 30, 2025, and June 30, 2024, respectively | 83,000 | 87,000 | 86,000 | 85,000 | 85,000 | |
| Additional paid-in capital | 22 | 21 | 19 | 18 | 17 | |
| Retained earnings | 21 | 24 | 19 | 16 | 15 | |
| Total shareholders equity | 43 | 45 | 38 | 34 | 32 | |
| Total liabilities and shareholders equity | 54 | 52 | 46 | 41 | 37 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation | 1 | 789,000 | 550,000 | 503,000 | 477,000 | |
| Impairment of intangible assets | 212,000 | 0 | — | — | — | |
| Amortization of finite-life intangible assets | 133,000 | 52,000 | 63,000 | 125,000 | 133,000 | |
| Share-based compensation expense | 3 | 2 | 708,000 | 976,000 | 1 | |
| Deferred income taxes | −310,000 | −571,000 | −43,000 | −489,000 | −294,000 | |
| Accounts receivable | −1 | 797,000 | −3 | −4 | −4 | |
| Contract assets | −317,000 | −232,000 | −201,000 | 107,000 | 510,000 | |
| Inventories | 175,000 | 459,000 | −1 | −1 | 971,000 | |
| Prepaid expenses and other assets | −959,000 | 1 | — | — | 151,000 | |
| Income tax receivable, net | −685,000 | −59,000 | — | — | — | |
| Accounts payable and accrued liabilities | 2 | −1 | 420,000 | 2 | 214,000 | |
| Accrued compensation | 1 | 875,000 | — | — | — | |
| Net cash provided by operating activities | 11 | 9 | 1 | −686,000 | 3 | |
| Expenditures for property and equipment | −262,000 | −287,000 | −2 | −1 | −287,000 | |
| Expenditures for finite-life intangible assets | −44,000 | −108,000 | −68,000 | −100,000 | −161,000 | |
| Net cash used for investing activities | −306,000 | −395,000 | −2 | −2 | −448,000 | |
| Issuance of common stock upon exercise of options | 398,000 | 311,000 | — | — | — | |
| Taxes paid on net share settlement of stock awards | −2 | 0 | −310,000 | −77,000 | −141,000 | |
| Repurchase of common stock | −10 | −275,000 | −153,000 | −1 | −1 | |
| Net cash (used for) provided by financing activities | −12 | 36,000 | −380,000 | −2 | −1 | |
| Net (decrease) increase in cash | −793,000 | 9 | −781,000 | −4 | 1 | |
| Cash paid for income taxes | 4 | 3 | 676,000 | 1 | 534,000 | |
| Property and equipment and intangible asset acquisitions in accounts payable | 107,000 | 4,000 | — | — | — | |
| Taxes owed on net share settlement of stock awards in accrued liabilities | 27,000 | 0 | — | — | — | |
| Demonstration equipment transferred between inventory and property and equipment | 238,000 | 50,000 | — | — | — | |
| Issuance of common stock upon the vesting of performance-based stock units | 1,000 | 0 | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Electromed, Inc.'s CIK number?
Electromed, Inc.'s SEC CIK number is 0001488917 (1488917). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Electromed, Inc.'s SEC filings?
All of Electromed, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Electromed, Inc. last report earnings?
Electromed, Inc. (ELMD) most recently filed an earnings 8-K with the SEC on May 12, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001437749-26-016422). This is Electromed, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Electromed, Inc.'s most recent earnings 8-K?
Electromed, Inc.'s latest earnings 8-K (Item 2.02) was filed May 12, 2026 under accession 0001437749-26-016422. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Electromed, Inc.'s latest earnings 8-K →
Look up any company's CIK number →